Psychological interventions for parents in pediatric palliative care may help reduce anxiety, depression, and overall psychological distress, according to a systematic review and meta-analysis of randomized controlled trials. Read more: https://www.emjreviews.com/oncology/news/psychological-support-for-parents-in-pediatric-palliative-care/

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 to treat malignant gliomas , including a particularly aggressive childhood brain tumor called diffuse intrinsic pontine glioma (DIPG). Read more: https://rarecancernews.com/news/fda-grants-amxt-1501-orphan-drug-status-malignant-gliomas/

Exposure to petrol compounds appears to be associated with an increased risk of childhood leukemia, including acute lymphoblastic leukemia (ALL), according to a systematic review published in  Blood and Lymphatic Cancer: Targets and Therapy . Read more: https://www.oncologynurseadvisor.com/news/parent-child-petrol-exposure-higher-childhood-leukemia-risk-treatment/

Timely, developmentally tailored diagnostic disclosure may reduce anxiety and strengthen coping among school-aged children with acute lymphoblastic leukemia (ALL), according to exploratory findings from Taiwan published in Patient Education and Counseling . Read more: https://www.oncologynurseadvisor.com/news/acute-leukemia-child-centered-disclosure-well-being-treatment-risk/

Immunotherapy has improved how doctors treat cancers all over the body, but so far it hasn’t been able to help children and young people with brain tumours. A discovery from researchers at the Cancer Research UK Cambridge Institute could finally change that. Read more: https://news.cancerresearchuk.org/2026/03/18/scientists-find-a-way-to-use-immunotherapy-to-treat-brain-tumours-in-children/

Survival outcomes are comparable or better with proton beam therapy (PBT) compared with photon radiotherapy (XRT) in pediatric patients with neuroblastomas, according to findings published in Cancer Medicine . Read more: https://www.cancertherapyadvisor.com/news/proton-beam-therapy-photon-radiotherapy-pediatric-neuroblastoma/

Liver cancer in children is rare, but when it occurs, the two main types are hepatoblastoma (HB) and hepatocellular carcinoma (HCC). In some cases, however, the tumors show features of both types. These tumors have been classified into a third tumor category called hepatoblastoma with carcinoma features (HBC). Read more: https://medicalxpress.com/news/2026-03-rare-pediatric-liver-cancer-emerges.html

Parental sense of coherence (SOC) “acts as a crucial mediator” between fear of disease progression and psychological distress among parents and caregivers of children with cancer, according to results from a recent study. Read more: https://www.cancernursingtoday.com/post/how-fear-of-progression-shapes-parental-distress-in-pediatric-cancer-care

The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer Institute. Read more: https://medicalxpress.com/news/2026-03-kind-analysis-reveals-variant-landscape.html

New research published in Nature finds that tumor cells within supratentorial ependymomas (SE)—an aggressive childhood brain cancer—cluster into distinct tumor cell populations. Read more: https://medicalxpress.com/news/2026-03-distinct-tumor-neighborhoods-treatments-aggressive.html